Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins

Journal of Neurochemistry

Volumn 135, Issue 6, 2015, Pages 1178-1188

  Wu, Kuo Chen ^a   Lu, Ya Hsuan ^a   Peng, Yi Hsuan ^a   Hsu, Lih Ching ^a   Lin, Chun Jung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; lipopolysaccharide; neurotoxin; PMAT

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROTOXIN; ORGANIC CATION TRANSPORTER; PLASMA MEMBRANE MONOAMINE TRANSPORTER; TETRAHYDROISOQUINOLINE; UNCLASSIFIED DRUG; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; SLC29A4 PROTEIN, HUMAN;

ANALYTICAL PARAMETERS; ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN CORTEX; BRAIN MICROVESSEL; BRAIN TO PLASMA RATIO; C57BL 6 MOUSE; CEREBELLUM; COCULTURE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCEPHALON; MICROVASCULATURE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT KINETICS; WESTERN BLOTTING; WISTAR RAT; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE; DRUG EFFECTS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CELL MEMBRANE; CELLS, CULTURED; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; NEUROTOXINS; ORGANIC CATION TRANSPORT PROTEINS; RATS, WISTAR;

EID: 84955186755     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13363     Document Type: Article

References (31)

1. Abbott N. J., Dolman D. E., Drndarski S., and, Fredriksson S. M., (2012) An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol. Biol. 814, 415-430.
2. Akanuma S. I., Uchida Y., Ohtsuki S., Tachikawa M., Terasaki T., and, Hosoya K. I., (2011) Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole. Fluids Barriers CNS 8, 24.
3. André P., Saubaméa B., Cochois-Guégan V., Marie-Claire C., Cattelotte J., Smirnova M., Schinkel A. H., Scherrmann J. M., and, Cisternino S., (2012) Transport of biogenic amine neurotransmetters at the mouse blood-retina and blood-brain barriers by uptake 1 and uptake2. J. Cereb. Blood Flow Metab. 32, 1989-2001.
4. + antiport activity, isoform expression, and localization in endothelial cells. Am. J. Physiol. 275, L442-L451.
5. Dahlin A., Xia L., Kong W., Hevner R., and, Wang J., (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146, 1193-1211.
6. DeCuypere M., Lu Y., Miller D. D., and, LeDoux M. S., (2008) Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain. J. Neurochem. 107, 1398-1413.
7. Duan H., and, Wang J., (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J. Pharmacol. Exp. Ther. 335, 743-753.
8. Engel K., Zhou M., and, Wang J., (2004) Identification and characterization of a novel monoamine transporter in the human brain. J. Biol. Chem. 279, 50042-50049.
9. Gerweck L. E., and, Seetharaman K., (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194-1198.
10. +-independent choline transporter in rat astrocytes. J. Neurochem. 94, 1427-1437.
11. Itagaki S., Ganapathy V., Ho H. T., Zhou M., Babu E., and, Wang J., (2012) Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab. Dispos. 40, 1138-1143.
12. Jakowec M. W., and, Petzinger G. M., (2004) 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates. Comp. Med. 54, 497-513.
13. Kotake Y., Tasaki Y., Makino Y., Ohta S., and, Hirobe M., (1995) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J. Neurochem. 65, 2633-2638.
14. Kotake Y., Tasaki Y., Hirobe M., and, Ohta S., (1998) Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies. Brain Res. 787, 341-343.
15. Kubo Y., Ohtsuki S., Uchida Y., and, Terasaki T., (2015) Quantitative determination of luminal and abluminal membrane distributions of transporters in porcine brain capillaries by plasma membrane fractionation and quantitative targeted proteomics. J. Pharm. Sci. 104, 3060-8.
16. Levitt P., Pintar J. E., and, Breakefield X. O., (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl Acad. Sci. USA 79, 6385-6389.
17. Lin C. J., Tai Y., Huang M. T., Tsai Y. F., Hsu H. J., Tzen K. Y., and, Liou H. H., (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J. Neurochem. 114, 717-727.
18. Maruyama W., Abe T., Tohgi H., Dostert P., and, Naoi M., (1996) A dopaminergic neurotoxin (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid. Ann. Neurol. 40, 119-122.
19. Morgan E. T., Goralski K. B., Piquette-Miller M., et al,. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos. 36, 205-216.
20. Nakagawa S., Deli M. A., Kawaguchi H., Shimizudani T., Shimono T., Kittel A., Tanaka K., and, Niwa M., (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54, 253-263.
21. Okura T., Kato S., Takano Y., Sato T., Yamashita A., Morimoto R., Ohtsuki S., Terasaki T., and, Deguchi Y., (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J. Pharm. Sci. 100, 3924-3938.
22. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J., and, Crews F. T., (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462.
23. Sipos H., Törocsik B., Tretter L., and, Adam-Vizi V., (2005) Impaired regulation of pH homeostasis by oxidative stress in rat brain capillary endothelial cells. Cell. Mol. Neurobiol. 25, 141-151.
24. Taylor C. J., Nicola P. A., Wang S., Barrand M. A., and, Hladky S. B., (2006) Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J. Physiol. 576, 769-785.
25. Wasik A., Romanska I., and, Antkiewicz-Michaluk L., (2009) 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies. Neurotox. Res. 15, 15-23.
26. Wu K. C., Lu Y. H., Peng Y. H., Tsai T. F., Kao Y. H., Yang H. T., and, Lin C. J., (2015) Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice. J. Cereb. Blood Flow Metab. 35, 37-47.
27. Xia L., Engel K., Zhou M., and, Wang J., (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am. J. Physiol. Renal. Physiol. 292, F682-F690.
28. Xiao F., Juric M., Li J., et al,. (2012) Loss of downregulated in adenoma (DRA) impairs mucosal HCO3- secretion in murine ileocolonic inflammation. Inflamm. Bowel Dis. 18, 101-111.
29. Yeh S. Y., Pan H. J., Lin C. C., Kao Y. H., Chen Y. H., and, Lin C. J., (2012) Hyperglycemia-induced down-regulation of renal P-glycoprotein expression. Eur. J. Pharmacol. 690, 42-50.
30. Yoshikawa T., Naganuma F., Iida T., Nakamura T., Harada R., Mohsen A. S., Kasajima A., Sasano H., and, Yanai K., (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61, 905-916.
31. Zhang Y., Schuetz J. D., Elmquist W. F., and, Miller D. W., (2004) Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 311, 449-455.